| Many patients with SARS-CoV-2 infection have underlying chronic medical conditions. |
| Patient-related outcomes are worse if there are associated comorbidities. |
| Insulin resistance and cardiovascular disease contribute to the increased severity of COVID-19. |
| Management of dysglycemia, hypertension, and dyslipidemia should be targeted individually in patients with COVID-19 infection. |
| SARS-CoV-2 patients are vulnerable to the development of thromboembolic disease. A personalized approach to antithrombotic/thromboembolism prophylaxis is recommended. |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.